Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback